Cite
HARVARD Citation
Thielmann, C. et al. (2021). NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors. European journal of cancer. pp. 113-124. [Online].